Suchen und Finden
Service
Biological and Bio-inspired Nanomaterials - Properties and Assembly Mechanisms
Sarah Perrett, Alexander K. Buell, Tuomas P.J. Knowles
Verlag Springer-Verlag, 2019
ISBN 9789811397912 , 439 Seiten
Format PDF, OL
Kopierschutz Wasserzeichen
Contents
5
1 Dynamics and Control of Peptide Self-Assembly and Aggregation
7
1.1 Introduction
8
1.2 Kinetic Theory of Protein Aggregation
9
1.2.1 Fundamental Processes in Protein Aggregation
9
1.2.2 The Master Equation: Quantifying the Kinetics of Aggregation
11
1.2.3 Principal Moments and Moment Equations
14
1.2.3.1 Principal Moments
14
1.2.3.2 Moment Equations
15
1.2.3.3 Common Approximations
15
1.2.4 Solving the Moment Equations: The Fixed-Point Method
17
1.2.5 Implications from Integrated Rate Laws
18
1.2.5.1 Early-Time Behaviour is Exponential
19
1.2.5.2 Half-Times and Scaling Exponents
20
1.3 The Full Aggregation Network: Interplay and Competition
21
1.3.1 Monomer Dependence of the Scaling Exponent as a Guide to Complex Mechanisms
21
1.3.2 Saturation: Processes in Series
23
1.3.2.1 Multi-step Elongation
24
1.3.2.2 Multi-step Primary Nucleation
26
1.3.2.3 Multi-step Secondary Nucleation
26
1.3.3 Competition: Processes in Parallel
27
1.3.3.1 Competition Between Primary and Secondary Processes
28
1.3.3.2 Two Competing Secondary Processes
28
1.3.4 Representing the Reaction Network
29
1.4 Application to Experiment: Global Fitting of Kinetic Data
31
1.5 Controlling Aggregation: Inhibitors and Solution Conditions
32
1.6 Conclusions
35
References
36
2 Peptide Self-Assembly and Its Modulation: Imaging on the Nanoscale
40
Abbreviations
40
2.1 Introduction
41
2.2 Peptide Self-Assembly Structures on Surfaces
42
2.3 Mutation/Modification Effects on Peptide Assemblies
45
2.4 Coassembly of Peptides with Small Molecules
49
2.4.1 Small Molecules Interacting with the Termini of Peptides
49
2.4.2 Small Molecules Interacting with the Side Groups of Peptides
52
2.5 Correlation of Peptide Assemblies on Surfaces and in Solution
56
2.6 Conclusions and Perspectives
59
References
59
3 The Kinetics, Thermodynamics and Mechanisms of Short Aromatic Peptide Self-Assembly
66
3.1 Introduction
67
3.2 The Nature of the Interactions Responsible for Peptide Assembly
68
3.2.1 Hydrogen Bonding
68
3.2.2 Hydrophobicity
70
3.2.3 Aromaticity in Proteins and Short Peptides
71
3.3 The Role of Phenylalanine Residues in Peptide Self-Assembly into Amyloid Fibrils
73
3.4 Experimental Methods to Study Short Peptide Assembly
74
3.4.1 The Choice of the Assembly Conditions for Self-Assembly
74
3.4.2 Microscopic Methods
76
3.4.3 Spectroscopic Methods
76
3.4.4 Scattering, Rheological, Calorimetric and Conductivity-Based Methods
77
3.4.5 Microfluidics
78
3.5 Thermodynamic Stability of Peptide Assemblies
79
3.5.1 Thermal Stability of FF Crystals
79
3.5.2 Chemical Stability of FF Crystals
80
3.5.3 Non-crystalline Short Aromatic Peptide Assemblies
81
3.5.3.1 Fibrils and Gels
81
3.5.3.2 Amorphous Materials
84
3.6 Mechanistic and Kinetic Description of Aromatic Peptide Assembly
87
3.6.1 Growth Processes
87
3.6.2 Nucleation Processes
90
3.7 Structure of Dipeptide Crystals with Particular Emphasis on FF
92
3.7.1 Hydrophobic Structures in Aromatic Dipeptides
93
3.7.2 Hydrogen Bond Connectivity in Aromatic Dipeptides
93
3.7.3 Macroscale Aggregate Structure
96
3.8 Comparison with the Assembly of Longer Sequences into Amyloid Fibrils
97
3.8.1 Structural Comparison
97
3.8.2 Comparison of Assembly Kinetics and Thermodynamics of Short Aromatic Peptides and Longer Amyloid Forming Sequences
101
3.9 Conclusions and Future Perspectives
106
References
107
4 Bacterial Amyloids: Biogenesis and Biomaterials
118
4.1 Introduction
119
4.2 The Curli System: Quality-Conscious and Made to Last
119
4.2.1 The Partnership of CsgB and CsgA: An Anchor for a Roving Sailor
121
4.2.2 All in the Fibril Family: Cooperation Within the Curli Operon
122
4.2.3 Younger Kid on the Block: Fap Fimbria Are Composed of Mainly FapC
124
4.2.4 Another Study in Team-Work: The Role of Fap Proteins
125
4.2.5 Other Bacterial Amyloid Systems
127
4.2.5.1 TasA: Cell Anchoring and Susceptibility to D-Amino Acids
127
4.2.5.2 MspA: The First Archaeal FuBA
132
4.2.5.3 Harpins: Green Oligomeric Weapons
132
4.2.5.4 Chaplins: Breaking the Air-Water Interface Barrier
132
4.2.5.5 Phenol-Soluble Modulins (PSM): Amyloid or Antimicrobial Agents?
133
4.3 Functional Amyloids in silico
133
4.3.1 Predicting Aggregation and Amyloid Propensity of Proteins Based on Sequences
133
4.3.1.1 Secondary Structure Propensity and Physico-Chemical Properties of Amino Acids
137
4.3.1.2 Statistical Potentials
137
4.3.1.3 Statistical Mechanical Models
138
4.3.1.4 Experimentally Driven Methods
139
4.3.1.5 Machine Learning Methods
139
4.3.1.6 Consensus Predictors
140
4.3.2 Detecting Amyloid Prone Sequences in Functional Amyloids
140
4.3.2.1 Sequence-Based Methods Can Detect Amyloidogenic Segments in Biofilm-Associated Proteins
140
4.3.2.2 Searching for Prion-like Domains Can Uncover Previously Unknown Functional Amyloids
140
4.3.2.3 The Existence of Imperfect Repeats Is Common to Many Functional Amyloids
141
4.3.3 Identifying Functional Amyloids Based on Their Evolved Characteristics
141
4.3.3.1 Searching for Functional Amyloid Homologues in Large Sequence Databases Reveals Functional Amyloid Sequence Diversity, Phylogeny, and Operon Structure
142
4.3.3.2 Techniques Targeting Evolved Characteristics May Find Unknown Functional Amyloids
143
4.3.4 Structure Prediction and Simulations of Functional Amyloids
144
4.3.4.1 Molecular Modeling Techniques Can Propose Structural Models of Functional Amyloids without Experimental Structural Data Using Evolutionary Constraints
144
4.3.4.2 Simulation Can Help to Elucidate the Molecular Details of Functional Amyloid Formation
145
4.4 Uses for Functional Amyloid: Brave New Nanomaterials
146
4.4.1 C-DAG as a Screen for Amyloid: How to Hijack a Robust Amyloid Export System
146
4.4.1.1 Generating New Binding Properties: How to Hitch a Ride on the Amyloid Ladder
147
4.4.1.2 Amyloid as Underwater Glue: Fusing CsgA to Mussel Foot Proteins
148
4.4.1.3 Controlled Combination of Different Amyloid: The Power of Riboregulators
148
4.4.2 Controlling Amyloid with Co-Factors: The Case of the Missing Calcium
150
4.4.3 Inclusion Bodies with Tunable Porosity: Nanopills for Drug Delivery?
151
4.4.4 Other Amyloid Uses: From Macroscale Films to Bone Replacement and Tissue Engineering
151
4.5 Perspectives
152
4.5.1 Challenges in the Development of New Amyloid-Based Biomaterials and -Medicine
153
References
154
5 Fungal Hydrophobins and Their Self-Assembly into Functional Nanomaterials
165
5.1 Introduction
166
5.2 The Discovery of Hydrophobins
166
5.3 Class I and Class II Hydrophobins
168
5.4 Structures of Class I and Class II Hydrophobins
170
5.5 The Surface Activity of Hydrophobins
171
5.6 Mechanism of Hydrophobin Assembly from Monomer to Amphipathic Monolayer
172
5.7 Hydrophobins Have Multiple Functions in the Fungal Life Cycle
175
5.7.1 Hydrophobin Coatings Shield Fungal Structures from Host Immune Recognition
175
5.7.2 Hydrophobins Facilitate Attachment of Fungi to Host Cells for Colonisation
177
5.8 Harnessing Hydrophobins for Biotechnological Purposes
177
5.8.1 Hydrophobins Used to Modify or to Functionalise Surfaces
178
5.8.2 Hydrophobins Used to Coat Stents for Anti-Fouling Properties
181
5.8.3 Hydrophobins Used to Stabilise Emulsions
181
5.8.4 Hydrophobins Applied for Improved Drug Delivery
182
5.9 Conclusions
183
References
184
6 Nanostructured, Self-Assembled Spider Silk Materials for Biomedical Applications
190
6.1 Introduction
190
6.2 Natural Spider Silk
191
6.2.1 Protein Composition of Major Ampullate Silk
192
6.2.2 Processing of Spider Silk Proteins into Fibers
193
6.2.3 Structure-Mechanics Relationships
194
6.3 Recombinant Spider Silk Proteins
197
6.3.1 Self-Assembly of Artificial Spider Silk Proteins
197
6.3.2 Materials Made of Recombinant Spider Silk Proteins
199
6.3.2.1 Nanofibrils
199
6.3.2.2 Hydrogels
203
6.3.2.3 Particles
203
6.3.2.4 Capsules
203
6.3.2.5 Films
204
6.3.2.6 Foams and Sponges
204
6.4 Biomedical Applications of Spider Silk
205
6.4.1 Drug Delivery and Deposition
206
6.4.2 Tissue Engineering
207
6.4.2.1 Wound Healing Scaffolds
208
6.4.2.2 Bone Tissue Engineering
209
6.4.2.3 Nerve Tissue Engineering
210
6.4.2.4 Implant Coating
211
6.5 Biofabrication
212
6.6 Conclusions
214
References
214
7 Protein Microgels from Amyloid Fibril Networks
225
7.1 Nature of Amyloid Proteins
226
7.1.1 Introduction
226
7.1.2 Detection of Amyloid Structures
229
7.1.3 Structure of Amyloid Fibrils
229
7.1.4 Self-Assembly and Polymorphism of Amyloid Fibrils
231
7.1.5 Mechanical Properties of Amyloid Fibrils
232
7.2 Amyloid Proteins for the Development of Functional Microgels
234
7.2.1 Emerging Applications of Artificial Amyloid Protein-Based Materials and Microgels
234
7.2.1.1 Amyloid Microgels as Drug Carrier Agents
235
7.2.2 Microgel and Microcapsule Formation
236
7.2.2.1 Microgel Formation Techniques
236
7.2.2.2 Structural Changes Accompanying the Formation of Protein Microgels and Protein Microgel Stability
239
7.2.3 Case Study: The Development of Protein Microgels and Gel Shells from Amyloid Fibril Networks as Drug Carrier Agents
241
7.2.4 Multiphase Protein Microgels – Phase Separation Phenomenon in Microgels
245
7.2.5 Microgels from All-Aqueous Emulsions Stabilized by Amyloid Nanofibrils
247
7.2.6 Functionalized Proteinaceous Microgels
250
7.3 Conclusions
253
References
253
8 Protein Nanofibrils as Storage Forms of Peptide Drugs and Hormones
266
8.1 Introduction
266
8.2 Functional Amyloids
269
8.3 Amyloids as a Depot for Protein/Peptide Storage and Release
269
8.4 Amyloid as Long-Acting Depot Formulations
277
8.5 Conclusion
284
References
285
9 Nanozymes: Biomedical Applications of Enzymatic Fe3O4 Nanoparticles from In Vitro to In Vivo
292
Abbreviations
292
9.1 Introduction
293
9.2 Basic Features of Fe3O4 Nanozymes
294
9.2.1 Activities of Fe3O4 Nanozymes
294
9.2.2 Kinetics and Mechanism of Fe3O4 Nanozymes
295
9.2.3 Advantages of Fe3O4 Nanozymes
296
9.3 Biomedical Applications of Fe3O4 Nanozymes
298
9.3.1 In Vitro Bioassays
298
9.3.2 Ex Vivo Tracking and Histochemistry Diagnosis
300
9.3.3 In Vivo Oxidative Stress Regulation
302
9.3.4 Hygiene and Dental Therapy
305
9.3.5 Eco Environment Applications
306
9.4 Summary and Future Perspectives
307
References
308
10 Self-Assembly of Ferritin: Structure, Biological Function and Potential Applications in Nanotechnology
314
10.1 Introduction
315
10.2 Historical Perspective
315
10.3 Ferritin: Basic Biology
317
10.4 Ferritin Protein Family
318
10.5 Structure of Ferritin
320
10.6 Application of Ferritin in Nanotechnology
322
10.7 Drug Delivery and Ferritin
323
10.8 Surface Modification and Cellular Interactions of Ferritin Nanoparticles
324
10.9 Other Potential Applications of Ferritin
325
10.10 Conclusions and Future Perspectives of Ferritin in Nano-biology
326
References
327
11 DNA Nanotechnology for Building Sensors, Nanopores and Ion-Channels
331
11.1 Self-Assembly with DNA
332
11.1.1 DNA Lattices and Tiles
332
11.1.2 DNA Origami
334
11.1.3 Design and Assembly of DNA Nanostructures
336
11.1.3.1 Conceiving the Target Shape
336
11.1.3.2 Crossover Rules for DNA Nanostructures
337
11.1.3.3 Computational Tools for DNA Nanotechnology
338
11.1.3.4 Assembly and Stability of DNA Nanostructures
340
11.1.4 Experimental Characterisation of DNA Nanostructures
341
11.1.4.1 UV-Vis Spectroscopy
341
11.1.4.2 UV Melting Profile
341
11.1.4.3 Gel Electrophoresis
342
11.1.4.4 Dynamic Light Scattering
343
11.1.4.5 AFM and TEM
344
11.1.4.6 DNA-PAINT
345
11.1.4.7 Functionalisation of DNA
345
11.2 DNA Sensors and Nanopores
346
11.2.1 Nanomechanical DNA-Based Sensors
347
11.2.1.1 Molecular Sensors
347
11.2.1.2 Environmental Sensors
348
11.2.2 Nanopores for Single-Molecule Detection
348
11.2.3 DNA Nanotechnology for Enhanced Nanopore Sensing
350
11.2.4 DNA Origami Hybrid Nanopores
352
11.2.4.1 Nanopore Architecture By Design
353
11.2.4.2 Tunable Pore Diameter
353
11.2.4.3 High Specificity
353
11.2.4.4 Stimuli Response
354
11.2.4.5 Ease of Fabrication
354
11.3 Synthetic Membrane Nanopores
355
11.3.1 Membrane Pores in Nature
356
11.3.2 Milestones of Synthetic Membrane Pores
357
11.3.3 DNA-Based Membrane Pores
359
References
362
12 Bio Mimicking of Extracellular Matrix
371
Abbreviations
371
12.1 Introduction
372
12.2 The Extracellular Matrix
373
12.3 Classification of Biomaterials
374
12.4 Synthetic Biomaterials
375
12.4.1 Metallic Biomaterials
375
12.4.2 Ceramic Biomaterials
377
12.4.3 Synthetic Biodegradable Polymers
379
12.5 Natural Biomaterials
380
12.5.1 Collagen
380
12.5.2 Alginate
382
12.5.3 Cellulose
384
12.5.4 Chitin-Chitosan
384
12.6 Natural and Synthetic Composite Biomaterials
385
12.7 Supramolecular Soft Biomaterials (Hydrogels)
386
12.8 How to Design the Molecular Building Blocks for Hydrogels
386
12.8.1 Mimicking the Microarchitecture of the Native ECM with Engineered Scaffolds
386
12.8.2 Microarchitecture of Tissue-Engineered Scaffolds
387
12.9 Hydrogel Degradation
389
12.10 Bioadhesion and Bioactivity
389
12.11 3D Structures of Hydrogels
390
12.12 Conclusions
391
References
392
13 Bioinspired Engineering of Organ-on-Chip Devices
400
Abbreviations
401
13.1 Introduction
401
13.2 Microfluidic Cell Culture System
402
13.3 Microengineering the Cellular Microenvironment
404
13.3.1 Cell-Matrix Interaction
405
13.3.2 Cell-Cell Interactions
405
13.3.3 Control of Biochemical Microenvironments
406
13.3.3.1 Gradients of Soluble Factors
406
13.3.3.2 Control of Oxygen Concentration
407
13.3.4 Control of Biophysical Microenvironments
408
13.3.4.1 Fluid Flow-Induced Stress
408
13.3.4.2 Tissue Mechanics
409
13.4 From Cells-on-Chip to Organs-on-Chips
409
13.4.1 Bioengineering Organs on Chip
414
13.4.1.1 Lung on a Chip
414
13.4.1.2 Gastrointestines on a Chip
415
13.4.1.3 Liver on a Chip
417
13.4.1.4 Heart on a Chip
418
13.4.1.5 Blood-Brain-Barrier on Chip
419
13.4.1.6 Multiple Organs on a Chip
419
13.4.2 Integrated Analysis System
421
13.5 Proof-of-Concept Applications of Organs-on-Chip
422
13.5.1 Disease Modeling
422
13.5.1.1 Inflammatory-Related Diseases
422
13.5.1.2 Brain diseases on Chip
423
13.5.1.3 Cancers on Chip
424
13.5.2 Drug Testing
425
13.5.2.1 Efficacy and Toxicity Testing
425
13.5.2.2 Pharmacokinetic and Pharmacodynamic Studies
427
13.5.3 Host-Microbe Interaction
429
13.6 Conclusion and Outlooks
430
References
431